| |
| FDA Official and Title | Date and Site | Other FDA Participants | Non-FDA Participants | Subject |
---|---|---|---|---|---|
Marlene E. Haffner, MD, MPH, Director Office of Orphan products Development | 8/12/99 Rockville, MD | John McCormick, MD, Deputy Director, Office of Orphan Products Development; Henry Startzman, MD; Melvin Lessing | Vicki Latter, MD, Dir. R&D, CP Pharm. Ltd.; Gordon Urquhart, Head Regulatory & Medical Info., CP Pharm. Ltd.; Donald Knight, US Reg. Consultant, CP Pharm. Limited | The designation & development of an orphan drug | |
Joseph A. Levitt, Director, Center for Food Safety and Applied Nutrition | 8/11 Washington, DC | Janice Oliver, LeeAnne Jackson, Ellen Morrison, Jack Guzewich, George Jackson, John Kvenberg, Camilla Brewer, Ruth Welch, Rosemary Gary | Luis G. Flores (PIPAA/Guatemala); Roberto Castaneda (Pres.) Guatemala Berry Commission; William Stixrud (Ambassador of Guatemala); Joseph D. Mooney (Coordinator of the High Level Commission) | Recent outbreaks of cyclosporiasis |
August 16, 1999